Shilajit: Purified Extract Evidence and Product Safety

The randomized studies cited here used named purified or standardized preparations. A resin’s colour, texture or place-of-origin story does not demonstrate that it matches those interventions. The more recent uncontrolled resin study also used a particular product and short protocol.^{See reference 1,See reference 2,See reference 3,See reference 4}

The artwork represents dark resin, a spatula and mineral rock. It does not certify purification, measured mineral content or a safe serving. Keep the actual preparation, ingredient amounts and quality documentation beside any product comparison.

The 2016 randomized trial studied healthy men aged forty-five to fifty-five using purified shilajit at 250 mg twice daily for ninety days. It reported increases in selected androgen measurements compared with placebo. The amount identifies that experiment; it is not a recommendation for a reader.^{See reference 1}

The trial does not establish treatment for a diagnosed hormone disorder, a benefit in women or a result from every resin. An individual hormone value, symptoms and any treatment decision need clinical assessment. Do not use the headline to bypass that separate question.^{See reference 1}

A 2022 trial assigned sixty postmenopausal women with osteopenia to placebo or a standardized aqueous extract, at 250 or 500 mg/day, for forty-eight weeks. It reported attenuation of bone-mineral-density loss and changes in associated markers.^{See reference 2}

Those findings are preliminary evidence about a selected population and preparation. They do not establish fewer fractures or a replacement for an osteoporosis assessment. The two research amounts also do not identify the right exposure for a commercial resin or an individual reader.^{See reference 2}

The 2019 exercise trial involved sixty-three recreationally active men and compared 250 or 500 mg/day with placebo over eight weeks. A favourable fatigue-related strength result was reported in a subgroup with stronger initial performance. That narrower analysis is important when interpreting a broad strength headline.^{See reference 3}

A subgroup finding is a reason to ask how it was selected and whether it is confirmed elsewhere. It cannot be rewritten as assured performance, muscle growth or recovery in all users. The tested extract, endpoint and analysis should remain attached to the claim.^{See reference 3}

The 2026 resin study followed twenty-five men for twenty-eight days in an open-label, single-arm design. Its reported before-and-after outcomes lack a comparator. Expectation, background changes and ordinary variation therefore remain alternative explanations.^{See reference 4}

This study can help describe a research question, but cannot confirm superiority over a purified extract or placebo. Nor does it permit the controlled-trial results to be assigned to all resin products. A current publication date is not a quality rating.^{See reference 4}

NCCIH warns that some Ayurvedic preparations contain metals such as lead, mercury or arsenic. That broad safety warning is relevant to product review, but it does not prove contamination in every shilajit batch. A product-specific conclusion needs product-specific evidence.^{See reference 5}

Check whether documentation identifies the exact lot, tests relevant contaminants and comes from an appropriate laboratory. Ask what purification or standardisation means for this material. A genuine certificate may answer a quality question; it cannot establish a hormone, bone or longevity benefit by itself.